Enzymotec   Report issue

For profit Phase 4
Founded: Migdal Hameq Israel (1998)
Status: Acquired by Frutarom Netherlands B.V. (2017)

Organization Overview

First Clinical Trial
2007
NCT00441480
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree